NFKB1 and lung cancer: We noticed that some clinical studies reporting NF‐κB expression detected by IHC that they correlated with clinicopathological characteristics and/or survival in lung cancers had conflicting results; summarized in Table 3, 7, 8, 9, 10, 11, 12, 13, 14, 15.